In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
395 News Items found
Old man lying in hospital bed being spoken to by nurse
Q&A
Keeping Patients out of the Hospital: MSK Geriatrics Specialist Explains the Keys to Caring for Older People with Cancer

An MSK geriatrician discusses the importance of helping older people with cancer manage their treatment and symptoms.
An illustration of sugar pouring onto NRF2
Finding
Sugar Directly Controls a Cancer-Causing Protein, Scientists Find

The discovery suggests a potential new treatment approach for certain cancers.
Tammela Lab
Cancer Risk Declines in Old Age, New MSK Research Helps Explain Why

A new laboratory study provides evidence about how advanced age can be protective against cancer — with implications for treating patients in different age groups.
MSK physician-scientist Dr. Charles Sawyers
In the Lab
New Insights Show ASCL1’s Role in Neuroendocrine Prostate Cancer, an Aggressive and Treatment-Resistant Type

Read about a powerful research model developed by MSK researchers to learn how the most common type of prostate cancer changes into a deadly form.
pathology assistant Fausto Gonzalez
In the Clinic
What’s New in Sarcoma Treatment? MSK Researchers Are Leading Many Innovative Clinical Trials

MSK’s sarcoma team is dedicated to developing new approaches for treating people with this rare cancer.
Amy Speck
Feature
Robotic Neurosurgery at MSK Speeds Recovery From Some Spinal Tumors

MSK surgeons have regularly used robotic surgery since 2007 to remove certain tumors in the chest and abdominal cavity. Now they are using robotic surgery to remove noncancerous tumors of the spine.
Gloved hand and magnifying glass on banded DNA sequences
Announcement
FDA Authorizes MSK-IMPACT Test for Analyzing Patient Tumors

The test, developed at MSK, looks for alterations in 468 genes that are seen in both common and rare cancers.
Dermatologist examining skin on the face of older man.
In the Clinic
Immunotherapy Drug Shows Promise for Metastatic Merkel Cell Carcinoma

An immunotherapy drug might be an effective initial treatment for people with metastatic Merkel cell carcinoma.
Memorial Sloan Kettering surgeon Daniela Molena
In the Clinic
When Is Heartburn a Sign of Esophageal Cancer?

Many people don’t know that gastroesophageal reflux disease (GERD) is a potentially serious condition that — if left untreated — can ultimately lead to esophageal cancer.
Pictured: Eric Holland, Franziska Michor, and Desert Horse-Grant
New Center Uses Mathematical Models to Understand Cancer

In October 2009, a team of eight researchers, six of whom are at Memorial Sloan Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States.